Danaher Corporation $DHR Shares Sold by Confluence Wealth Services Inc.

Confluence Wealth Services Inc. cut its holdings in Danaher Corporation (NYSE:DHR) by 28.3% during the 2nd quarter, Holdings Channel reports. The firm owned 1,521 shares of the conglomerate’s stock after selling 600 shares during the period. Confluence Wealth Services Inc.’s holdings in Danaher were worth $300,000 at the end of the most recent reporting period.

Other institutional investors have also recently modified their holdings of the company. NBC Securities Inc. acquired a new position in shares of Danaher in the first quarter worth $176,000. Vest Financial LLC raised its stake in Danaher by 73.6% in the 1st quarter. Vest Financial LLC now owns 5,361 shares of the conglomerate’s stock valued at $1,099,000 after purchasing an additional 2,273 shares during the last quarter. Patriot Financial Group Insurance Agency LLC lifted its holdings in Danaher by 7.2% in the 1st quarter. Patriot Financial Group Insurance Agency LLC now owns 1,067 shares of the conglomerate’s stock valued at $219,000 after purchasing an additional 72 shares in the last quarter. Capital Investment Advisors LLC boosted its stake in shares of Danaher by 28.8% during the 1st quarter. Capital Investment Advisors LLC now owns 7,267 shares of the conglomerate’s stock worth $1,490,000 after purchasing an additional 1,627 shares during the last quarter. Finally, Courier Capital LLC boosted its stake in shares of Danaher by 77.3% during the 1st quarter. Courier Capital LLC now owns 3,733 shares of the conglomerate’s stock worth $765,000 after purchasing an additional 1,627 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Price Performance

Shares of Danaher stock opened at $211.65 on Tuesday. The business’s fifty day moving average price is $200.36 and its 200 day moving average price is $197.24. Danaher Corporation has a twelve month low of $171.00 and a twelve month high of $279.41. The company has a current ratio of 1.62, a quick ratio of 1.22 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $151.55 billion, a P/E ratio of 45.03, a PEG ratio of 3.06 and a beta of 0.77.

Danaher (NYSE:DHR) last released its quarterly earnings data on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, topping analysts’ consensus estimates of $1.64 by $0.16. The company had revenue of $5.94 billion for the quarter, compared to the consensus estimate of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The company’s quarterly revenue was up 3.4% compared to the same quarter last year. During the same period last year, the business posted $1.72 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, research analysts anticipate that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be given a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date of this dividend is Friday, September 26th. Danaher’s payout ratio is 27.23%.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on DHR. Scotiabank raised shares of Danaher from a “sector perform” rating to a “sector outperform” rating and set a $275.00 price objective for the company in a research report on Friday, July 11th. Royal Bank Of Canada set a $241.00 price target on Danaher in a research note on Tuesday, September 2nd. Evercore ISI lowered their price objective on Danaher from $230.00 to $226.00 and set an “outperform” rating for the company in a research report on Tuesday, July 8th. Wells Fargo & Company reduced their target price on Danaher from $210.00 to $205.00 and set an “equal weight” rating on the stock in a research report on Wednesday, July 23rd. Finally, Wall Street Zen raised Danaher from a “hold” rating to a “buy” rating in a research note on Friday, June 27th. Seventeen analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $245.91.

Insiders Place Their Bets

In other Danaher news, Director Teri List sold 2,778 shares of the business’s stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the sale, the director directly owned 20,751 shares in the company, valued at $4,379,706.06. The trade was a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 11.10% of the stock is currently owned by company insiders.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.